Opsiscare Lifesciences Pvt Ltd
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Opglim MV 1mg/500mg/0.2mg Tablet is a combination of anti-diabetic drugs used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Tablet
Opglim MV 1mg/500mg/0.2mg Tablet is a combination of three antidiabetic medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes. Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol, or if you delay or miss a meal. Carry a sugar source with you for immediate relief.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush, or break it. Opglim MV 1mg/500mg/0.2mg Tablet is to be taken empty stomach.
Opglim MV 1mg/500mg/0.2mg Tablet is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol, or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Opglim MV 1mg/500mg/0.2mg Tablet is a combination of three medicines: Glimepiride, Metformin and Voglibose. This medicine is used in the treatment of type 2 diabetes mellitus (DM). It improves blood glucose levels in adults when taken along with proper diet and regular exercise. Glimepiride lowers blood glucose levels by increasing insulin release from the pancreas. Metformin works by lowering glucose production in the liver and improving insulin sensitivity. Voglibose is an alpha-glucosidase inhibitor that lowers postprandial (after meals) glucose levels in the body.
Common side effects of Opglim MV 1mg/500mg/0.2mg Tablet include hypoglycemia (low blood sugar level), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash and respiratory tract infection.
Avoid using Opglim MV 1mg/500mg/0.2mg Tablet if you are allergic to any of the components or excipients of this medicine. It is also not recommended for patients with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations and underlying metabolic acidosis including diabetic ketoacidosis.
No, alcohol should not be taken with Opglim MV 1mg/500mg/0.2mg Tablet. It can lower blood sugar levels (hypoglycemia) and increase the risk of lactic acidosis.
Yes, Opglim MV 1mg/500mg/0.2mg Tablet can cause hypoglycemia (low blood sugar level). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. It's more likely to occur if you miss meals, drink alcohol, exercise excessively, or take other antidiabetic medications simultaneously. Regular monitoring of your blood glucose is crucial.
Store this medicine in its original packaging tightly closed. Refer to the package label for specific storage instructions. Do not use expired medication, ensure it is out of reach of children and pets.